Differences in infectivities and genomic structures between oncogenic and non-oncogenic Marek's disease viruses 腫瘍原性および弱毒マレック病ウイルスの遺伝子構造と感染性の相違に関する研究

この論文をさがす

著者

    • 李, 成一 イ, サンイル

書誌事項

タイトル

Differences in infectivities and genomic structures between oncogenic and non-oncogenic Marek's disease viruses

タイトル別名

腫瘍原性および弱毒マレック病ウイルスの遺伝子構造と感染性の相違に関する研究

著者名

李, 成一

著者別名

イ, サンイル

学位授与大学

北海道大学

取得学位

博士 (獣医学)

学位授与番号

甲第5193号

学位授与年月日

2000-03-24

注記・抄録

博士論文

目次

  1. CONTENTS / (0003.jp2)
  2. PREFACE / p1 (0006.jp2)
  3. CHAPTER I / p9 (0014.jp2)
  4. RE-ISOLATION OF MAREK'S DISEASE VIRUS(MDV)FROM T CELL SUBSETS OF VACCINATED AND NON-VACCINATED CHICKENS / p9 (0014.jp2)
  5. INTRODUCTION / p10 (0015.jp2)
  6. MATERIALS AND METHODS / p11 (0016.jp2)
  7. RESULTS / p14 (0019.jp2)
  8. T cell tropism of MDV during the latent infection / p14 (0019.jp2)
  9. The effect of Marek's disease vaccines on the distribution of MDV in T cell subsets / p16 (0021.jp2)
  10. The differences in the cell tropism among virulent,attenuated and nononcogenie MDVs / p16 (0021.jp2)
  11. DISCUSSION / p19 (0024.jp2)
  12. SUMMARY / p23 (0028.jp2)
  13. CHAPTER II / p24 (0029.jp2)
  14. BINDING OF CELL-FREE MAREK'S DISEASE VIRUS TO HEPARIN IN VITRO / p24 (0029.jp2)
  15. INTRODUCTION / p25 (0030.jp2)
  16. MATERIALS AND METHODS / p26 (0031.jp2)
  17. RESULTS / p29 (0034.jp2)
  18. Infectivity of cell-free MDV in vitro and in vivo / p29 (0034.jp2)
  19. Inhibition of plaque formation by heparin or heparinase treatment / p32 (0037.jp2)
  20. DISCUSSION / p35 (0040.jp2)
  21. SUMMARY / p38 (0043.jp2)
  22. CHAPTER III / p39 (0044.jp2)
  23. DIFFERENCE IN THE MEQ GENE BETWEEN ONCOGENIC AND ATTENUATED STRAINS OF MAREK'S DISEASE VIRUS SEROTYPE 1 / p39 (0044.jp2)
  24. INTRODUCTION / p40 (0045.jp2)
  25. MATERIALS AND METHODS / p41 (0046.jp2)
  26. RESULTS / p43 (0048.jp2)
  27. PCR analysis of the meq gene of CVl988 / p43 (0048.jp2)
  28. Nucleotide sequence of the long meq ORF detected in CVl988 / p43 (0048.jp2)
  29. Southern blot analysis of the meq gene of CVl988 / p48 (0053.jp2)
  30. DISCUSSION / p48 (0053.jp2)
  31. SUMMARY / p53 (0058.jp2)
  32. CONCLUSION / p54 (0059.jp2)
  33. ACKNOWLEDGMENTS / p56 (0061.jp2)
  34. REFERENCES / p57 (0062.jp2)
  35. SUMMARY IN JAPANESE / p72 (0077.jp2)
  36. Re-isolation of Marek's disease virus from T cell subsets of vaccinated and non-vaccinated chickens / p45 (0081.jp2)
  37. Difference in the Meq Gene between Oncogenic and Attenuated Strains of Marek's Disease Virus Serotype 1 / p1 (0091.jp2)
  38. Seroprevalence of Bovine Immunodeficiency Virus in Dairy and Beef Cattle Herds in Korea / (0109.jp2)
  39. EXPRESSION OF BCL-2 AND BCL-X GENES IN LYMPHOCYTES AND TUMOR CELL LINES DERIVED FROM MDV-INFECTED CHICKENS / p128 (0112.jp2)
  40. マレック病ウイルス(MDV)感染鶏における免疫抑制とMD生ワクチンの作用機序(1) / p33 (0117.jp2)
  41. マレック病ウイルス(MDV)感染鶏における免疫抑制とMD生ワクチンの作用機序(2) / p25 (0126.jp2)
  42. RE-ISOLATION OF MAREK'S DISEASE VIRUS FROM T CELL SUBSETS OF VACCINATED AND NON-VACCINATED CHICKENS / p130 (0132.jp2)
0アクセス

各種コード

  • NII論文ID(NAID)
    500000189636
  • NII著者ID(NRID)
    • 8000000189919
  • DOI(NDL)
  • NDL書誌ID
    • 000000353950
  • データ提供元
    • NDL ONLINE
    • NDLデジタルコレクション
ページトップへ